Skip to main content

Search by tag

Number of hits: 13

  • Mathias Uhlén

    Dr. Mathias Uhlén, Professor of Microbiology.

  • Division of Nanobiotechnology

    The Division of Nanobiotechnology is focusing on interdisciplinary research with a focus to combine nanotechnology and microfluidics with various biotechnology and medical applications.

  • Next generation of cancer treatment: small proteins

    Imagine there was a drug for cancer treatment with almost zero side effects. And you wouldn´t have to take your medicine every fourth hour but every third week. We're closer to developing this kind of treatment than you might think.

  • Risks with aneurysm surgery made clearer with mathematical model, researchers say

    Even though operating on an abdominal aortic aneurysm can be risky, there are no patient-specific guidelines for deciding the optimal time for surgery. A mathematical model developed by Swedish researchers offers a way to guide doctors in making the right choices for individual patients.

  • Student team competing in Boston

    A team of students from KTH Royal Institute of Technology in Stockholm, the Karolinska Institute (KI), Stockholm University and Beckmans College of Design has just finished their part in iGEM, an international competition in synthetic biology at Massachusetts Institute of Technology (MIT) in Boston. The team’s competition entry is a solution that increases the efficiency of alternative treatment methods when the use of antibiotics does not help.

  • Brain depends on gut bacteria for protection

    With the abundance of information available about eating right, no one could question the capacity of your brain to protect your digestive tract. But a recent study shows that the intestines may in turn be protecting the brain, long before you’re old enough to surf health and nutrition websites.

  • They are putting a stop to forest devastation

    Pine weevils are real tree-killers and are munching away at the Swedish forests for SEK 100 million annually. This is a tough setback for a major branch of Swedish industry. Now, however, new tests have indicated that KTH researchers have implemented positive results in the fight against the pine weevil. In addition, the method is both non-toxic and inexpensive.

  • Expert panel praises KTH

    More than 100 international experts who have evaluated KTH Royal Institute of Technology’s research base have rated its Biotechnology research field as a Swedish flagship that could become Sweden’s answer to CERN. The experts have also concluded that KTH’s research base has a strong impact on society.

  • Breakthrough in the fight against fish death

    Each year 45.5 billion tonnes of fish throughout the world are cultivated; this has a value of EUR 41 billion. At least 10% of the fish, the equivalent of EUR 4.1 billion, die due to fungal-like parasites which are called oomycetes. New KTH research is however preparing a way to solving this problem.

  • KTH involved in major investment in biotechnology

    One of the largest research grants ever in Scandinavia, according to Mathias Uhlén, one of the three people in charge. A Nordic research centre is now to be created with nearly one billion Swedish crowns in its budget.

  • More effective anti-retroviral drugs for HIV-infected

    Improved retroviral drugs, new super-efficient cleansing agent and new plastics. This could be the result of a KTH student’s research developments.

  • Study illuminates how humans digest fibre

    New insight into how gut bacteria digest fibre could lead to advances in areas as diverse as health and environmentally-friendly biofuels.

  • First-ever look at potentially deadly metabolic disorder that strikes infants

    At the heart of one serious metabolic disorder is an enzyme whose inner workings and structure have been revealed for the first time by researchers at KTH.

Belongs to: KTH Royal Institute of Technology
Last changed: Sep 22, 2020